CME Credit | ASCRS
Winter Symposium

CME Credit

ASCRS gratefully acknowledges the unrestricted educational grants received in support of this program from:

- AbbVie
- Alcon Vision, LLC.
- Bausch + Lomb
- Johnson & Johnson Vision
- STAAR Surgical Company
- Sun Pharmaceuticals Industries, Inc.
- Tarsus Pharmaceuticals, Inc.

Continuing Medical Education (CME)

ACCME Accredited Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality, and scientific integrity of the CME activity.

Designation Statement
The American Society of Cataract and Refractive Surgery designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™, Physicians should claim credit commensurate with the extent of their participation in the activity. Physicians may claim credit for participation as follows:

Thursday: max 5.5 credits
Friday: max 5.5 credits
Saturday: max 4 credits

Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™. Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits.

Educational Objectives

Target Audience:

This educational activity is intended for ophthalmologists with an interest in anterior segment surgery.

Educational Objectives
Ophthalmologist attending this meeting will:

  • Recognize key elements and recent advances in diagnostic evaluation, intraocular lens calculations, and surgical techniques to improve cataract refractive outcomes to meet increased patient expectations.

  • Identify best practices in the management of complex and challenging cataract and anterior segment cases.

  • Discuss new intraocular lens designs for treating astigmatism and providing presbyopia correction.

  • Describe new advances in the surgical and medical management of glaucoma.

  • Prepare improved practice protocols for the screening, diagnosis, and treatment of corneal and external disease, including ocular surface and dry eye disease and demodex blepharitis.

  • Discuss new advances in corneal and refractive surgery.

  • Describe new pharmacologic approaches to treat presbyopia.

Program Evaluation & Credit Claim

All attendees must pick up their badge onsite to be verified as eligible for credit. Attendees will use the QR Code within the final program to access the program evaluation and CME Credit Claim. All QR Code claims must be completed by Sunday, February 13, 2021. Please contact Carrie Braden, Director of Continuing Medical Education, at with any questions on credit claims and/or verification of attendance. 

Scientific Integrity and Financial Interest Disclosure

Financial Interest Disclosures for all faculty are available within the Financial Interest section of the meeting website and within the final program. ASCRS is committed to ensuring that all continuing medical education (CME) information is based on the application of research findings and the implementation of evidence-based medicine. ASCRS seeks to promote balance, objectivity and absence of commercial bias in its content. All persons in a position to control the content of this activity must disclose all relevant financial interests. ASCRS has mechanisms in place to mitigate all conflicts of interest prior to an educational activity being delivered to learners. 

Notice of Off-Label Use Presentations

This program may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he/she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.